Gayatri BioOrganics Ltd
Incorporated in 1993, Gayatri Bio-Organics Ltd manufactures Starch, its derivatives and related by-products, and development of customized application for value added starch derivatives.
- Market Cap ₹ 59.0 Cr.
- Current Price ₹ 7.49
- High / Low ₹ 7.88 / 5.16
- Stock P/E
- Book Value ₹ -4.51
- Dividend Yield 0.00 %
- ROCE -44.5 %
- ROE %
- Face Value ₹ 10.0
Pros
Cons
- Company has low interest coverage ratio.
- Promoter holding has decreased over last quarter: -22.2%
- Promoter holding is low: 21.6%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Miscellaneous Industry: Miscellaneous
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
151.06 | 213.97 | 255.89 | 137.22 | 79.32 | 173.32 | 155.48 | 0.00 | 0.00 | 0.00 | 1.67 | 0.00 | 0.00 | |
139.18 | 201.10 | 240.58 | 162.03 | 128.53 | 197.18 | 159.09 | 0.61 | 0.50 | 0.50 | 2.44 | 0.53 | 0.52 | |
Operating Profit | 11.88 | 12.87 | 15.31 | -24.81 | -49.21 | -23.86 | -3.61 | -0.61 | -0.50 | -0.50 | -0.77 | -0.53 | -0.52 |
OPM % | 7.86% | 6.01% | 5.98% | -18.08% | -62.04% | -13.77% | -2.32% | -46.11% | |||||
0.12 | 0.30 | 1.27 | 0.96 | -16.53 | 11.87 | 2.10 | 85.09 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Interest | 7.48 | 7.57 | 9.39 | 12.74 | 11.57 | 0.19 | 4.71 | 0.01 | 0.00 | 0.00 | 0.03 | 0.15 | 0.26 |
Depreciation | 3.95 | 4.25 | 2.37 | 2.13 | 5.34 | 6.96 | 9.29 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Profit before tax | 0.57 | 1.35 | 4.82 | -38.72 | -82.65 | -19.14 | -15.51 | 84.47 | -0.50 | -0.50 | -0.80 | -0.68 | -0.78 |
Tax % | -56.14% | 0.00% | 18.26% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 26.25% | 0.00% | |
0.90 | 1.35 | 3.93 | -38.73 | -82.65 | -19.14 | -15.51 | 84.47 | -0.50 | -0.50 | -1.01 | -0.68 | -0.78 | |
EPS in Rs | 0.18 | 0.27 | 0.77 | -6.27 | -10.49 | -2.43 | -1.97 | 10.72 | -0.06 | -0.06 | -0.13 | -0.09 | -0.10 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | -100% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 14% |
3 Years: | -14% |
TTM: | 30% |
Stock Price CAGR | |
---|---|
10 Years: | 0% |
5 Years: | 40% |
3 Years: | -27% |
1 Year: | 25% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
Last Year: | % |
Balance Sheet
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 50.92 | 50.92 | 50.92 | 61.78 | 78.79 | 78.79 | 78.79 | 78.79 | 78.79 | 78.79 | 78.79 | 78.79 | 78.79 |
Reserves | -46.14 | -44.79 | -40.86 | -79.58 | -159.93 | -181.20 | -195.74 | -111.27 | -111.77 | -112.26 | -113.27 | -113.95 | -114.35 |
81.13 | 75.47 | 88.12 | 115.50 | 35.11 | 35.11 | 35.11 | 35.11 | 35.11 | 35.11 | 35.66 | 36.36 | 36.76 | |
32.60 | 94.72 | 43.94 | 44.00 | 150.81 | 212.77 | 226.93 | 0.46 | 0.47 | 0.60 | 0.44 | 0.37 | 0.44 | |
Total Liabilities | 118.51 | 176.32 | 142.12 | 141.70 | 104.78 | 145.47 | 145.09 | 3.09 | 2.60 | 2.24 | 1.62 | 1.57 | 1.64 |
52.54 | 48.88 | 47.19 | 45.69 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
CWIP | 0.37 | 0.37 | 5.80 | 6.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
65.60 | 127.07 | 89.13 | 90.00 | 104.78 | 145.47 | 145.09 | 3.09 | 2.60 | 2.24 | 1.62 | 1.57 | 1.64 | |
Total Assets | 118.51 | 176.32 | 142.12 | 141.70 | 104.78 | 145.47 | 145.09 | 3.09 | 2.60 | 2.24 | 1.62 | 1.57 | 1.64 |
Cash Flows
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
10.27 | 14.18 | 1.07 | -26.48 | -13.76 | -2.62 | -0.59 | 84.59 | -0.52 | -0.40 | -0.56 | -0.69 | |
-3.10 | 0.44 | -7.10 | -1.42 | -0.75 | 2.62 | 0.82 | -83.86 | 0.00 | 0.00 | 0.00 | 0.00 | |
-6.95 | -13.51 | 4.48 | 28.02 | 15.53 | 0.00 | 0.00 | -0.01 | 0.00 | 0.00 | 0.56 | 0.70 | |
Net Cash Flow | 0.22 | 1.11 | -1.55 | 0.12 | 1.02 | 0.00 | 0.23 | 0.73 | -0.52 | -0.40 | -0.01 | 0.01 |
Ratios
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 115.91 | 162.69 | 63.12 | 116.05 | 6.95 | 3.18 | 1.22 | 54.64 | ||||
Inventory Days | 38.29 | 51.08 | 62.87 | 98.30 | 0.00 | 0.00 | 0.00 | 0.00 | ||||
Days Payable | 79.15 | 177.53 | 58.80 | 79.17 | ||||||||
Cash Conversion Cycle | 75.05 | 36.24 | 67.19 | 135.18 | 6.95 | 3.18 | 1.22 | 54.64 | ||||
Working Capital Days | 40.96 | 37.85 | 51.74 | 87.49 | -211.86 | -141.75 | -192.90 | 251.35 | ||||
ROCE % | 9.44% | 10.65% | 14.68% | -27.28% | -209.87% | -21.01% | -26.53% | -54.61% | -44.54% |
Documents
Announcements
-
Board Meeting Intimation for Approval Of The Audited Financial Results Of The Company Along With Audit Report For The Quarter And Year Ended On 31.03.2025 And Induction Of New Directors On The Board Of The Company
2d - Board meeting on 28-May-2025 to approve FY25 results and induct new directors.
-
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
30 Apr - Gayatri Bioorganics confirms non-applicability of Large Corporate criteria as of 31-03-2025.
-
Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2
10 Apr - Non-applicability of Large Corporate criteria by Gayatri Bioorganics.
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
7 Apr - Compliance certificate under SEBI regulations for Q1 2025.
- Closure of Trading Window 24 Mar
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Product Profile:
a) Starch[1]
b) Sorbitol[2]
c) Liquid Glucose[3]
d) Corn Fiber[4]
e) Corn Germ[5]
f) Gluten[6]
g) Bio-Oxide-G[7]
h) Bio-Theen-G[8]
i) Bio-W-Dext-G[9]
j) Bio-Y-Dext-G[10]